AU6293798A - Polynucleotide associated with the bo or bor syndrome, its corresponding polypeptide and diagnostic and therapeutic applications - Google Patents

Polynucleotide associated with the bo or bor syndrome, its corresponding polypeptide and diagnostic and therapeutic applications

Info

Publication number
AU6293798A
AU6293798A AU62937/98A AU6293798A AU6293798A AU 6293798 A AU6293798 A AU 6293798A AU 62937/98 A AU62937/98 A AU 62937/98A AU 6293798 A AU6293798 A AU 6293798A AU 6293798 A AU6293798 A AU 6293798A
Authority
AU
Australia
Prior art keywords
diagnostic
therapeutic applications
corresponding polypeptide
polynucleotide associated
bor syndrome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU62937/98A
Inventor
Sonia Abdelhak
Sylvie Compain
Christine Petit
Kalatzis Vasiliki
Christophe Vincent
Dominique Weil
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Original Assignee
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur de Lille filed Critical Institut Pasteur de Lille
Publication of AU6293798A publication Critical patent/AU6293798A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Chemistry (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU62937/98A 1997-01-29 1998-01-28 Polynucleotide associated with the bo or bor syndrome, its corresponding polypeptide and diagnostic and therapeutic applications Abandoned AU6293798A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3657997P 1997-01-29 1997-01-29
US60036579 1997-01-29
PCT/EP1998/000433 WO1998032849A2 (en) 1997-01-29 1998-01-28 Polynucleotide associated with the bo or bor syndrome, its corresponding polypeptide and diagnostic and therapeutic applications

Publications (1)

Publication Number Publication Date
AU6293798A true AU6293798A (en) 1998-08-18

Family

ID=21889394

Family Applications (1)

Application Number Title Priority Date Filing Date
AU62937/98A Abandoned AU6293798A (en) 1997-01-29 1998-01-28 Polynucleotide associated with the bo or bor syndrome, its corresponding polypeptide and diagnostic and therapeutic applications

Country Status (2)

Country Link
AU (1) AU6293798A (en)
WO (1) WO1998032849A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1340818A1 (en) 2002-02-27 2003-09-03 Epigenomics AG Method and nucleic acids for the analysis of a colon cell proliferative disorder
WO2012112955A2 (en) 2011-02-17 2012-08-23 The Trustees Of Columbia University In The City Of New York Methods for identifying subjects with a genetic risk for developing iga nephropathy
WO2014169294A1 (en) * 2013-04-12 2014-10-16 The Trustees Of Columbia University In The City Of New York Mutations in dstyk cause dominant urinary tract malformations
CN112646878A (en) * 2021-01-22 2021-04-13 丁建强 Molecular marker for early diagnosis of liver injury diseases in serum
CN112746104A (en) * 2021-01-22 2021-05-04 丁建强 Molecular marker for early diagnosis of liver injury diseases in serum

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946773A (en) * 1985-12-23 1990-08-07 President And Fellows Of Harvard College Detection of base pair mismatches using RNAase A
SE9500341D0 (en) * 1995-01-30 1995-01-30 Ulf Landegren Method for detecting DNA sequence variations

Also Published As

Publication number Publication date
WO1998032849A2 (en) 1998-07-30
WO1998032849A3 (en) 1998-10-08

Similar Documents

Publication Publication Date Title
EP0678723A4 (en) The nizov crossbow.
EP0659820A3 (en) Composite media with selectable radiation-transmission properties.
WO1999046281A8 (en) Novel polypeptides and nucleic acids encoding the same
EP0655256A3 (en) Inhaler.
EP0677295A4 (en) Liposome having oligosaccharide on the surface.
EP0626257A3 (en) Vinyldoor panel section.
EP0659769A3 (en) Agent for promoting the proliferation of bifidobacterium.
PH31323A (en) Alkali-treated bagasse and its preparation and use.
HK1034248A1 (en) Cephalosporin antibiotics composition and the use thereof.
EP0614265A3 (en) Actuator with translational and rotational control.
AU1441195A (en) Phenylmethyl hexanamides, and the use thereof
EP0669396A4 (en) Novel polypeptide and dna coding for the same.
EP0606140A3 (en) Composite shaft with flexible features.
AU6293798A (en) Polynucleotide associated with the bo or bor syndrome, its corresponding polypeptide and diagnostic and therapeutic applications
AU1509501A (en) A novel polypeptide, a human deafness-related gene 14 and the polynucleotide encoding the polypeptide
EP0657693A3 (en) Gasburner.
AU8095598A (en) Hair-drier or the like
AU3599199A (en) Tumour-specific expression control region and the use thereof
EP0682072A3 (en) Resin composition and multilayered structure comprising the same.
AU1508601A (en) A novel polypeptide, a human histone h2a.21 and the polynucleotide encoding the polypeptide
EP0657679A3 (en) Connector unit, particularly of the multiple-connection rapid-engagement type.
EP0679076A4 (en) Invisible bandage assembly.
AU6087694A (en) The l-plastin promoter region and its uses
AU1378701A (en) A novel polypeptide, a human apoptosis associated protein 12 and the polynucleotide encoding the polypeptide
EP0617205A3 (en) Nail with enlarged section.